MDL-27,266

(преусмерено са MDL-27266)

MDL-27,266 je antagonist NMDA receptora.[3]

MDL-27,266
5-(4-chlorophenyl)-4-ethyl-2-methyl-1,2,4-triazol-3-one
Nazivi
IUPAC naziv
5-(4-hlorofenil)-4-etil-2-metil-1,2,4-triazol-3-on
Drugi nazivi
  • 116114-14-8
  • Mdl 27266
  • 2,4-Dihidro-5-(4-hlorofenil)-4-etil-2-metil-3H-1,2,4-triazol-3-on
  • 3H-1,2,4-Triazol-3-on, 5-(4-hlorofenil)-4-etil-2,4-dihidro-2-metil-
Identifikacija
3D model (Jmol)
  • CCN1C(=NN(C1=O)C)C2=CC=C(C=C2)Cl
Svojstva
C11H12ClN3O
Molarna masa 237,69 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.